The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Ursodeoxycholic Acid Market Research Report 2024
Synopsis
Ursodeoxycholic acid, whose chemical name is 3a,7β-dihydroxy-5β-cholestane-24-acid, is an organic compound with an odorless, bitter taste. It is used in medicine to increase the secretion of bile acid, change the composition of bile, reduce cholesterol and cholesterol lipid in bile, and help the cholesterol in gallstones to gradually dissolve.
Global Oral Ursodeoxycholic Acid market is projected to reach US$ 3436.9 million in 2029, increasing from US$ 1628 million in 2022, with the CAGR of 11.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Ursodeoxycholic Acid market research.
The Ursodeoxycholic Acid (UDCA) drug market is driven by the increasing prevalence of liver and gallbladder disorders and the growing adoption of UDCA as an effective treatment option. UDCA is a naturally occurring bile acid that helps dissolve cholesterol-rich gallstones and aids in the treatment of certain liver diseases, such as primary biliary cholangitis (PBC) and nonalcoholic fatty liver disease (NAFLD). The rise in liver-related conditions and the need for improved therapeutic options contribute to market growth as UDCA offers a well-tolerated and disease-modifying treatment for these disorders. Moreover, advancements in drug formulations and the development of combination therapies have enhanced the efficacy of UDCA treatment. However, the market also faces challenges, including the cost of UDCA drugs and the need for further research to optimize dosing and treatment protocols. Additionally, addressing regulatory requirements and ensuring accessibility to patients can pose obstacles for broader adoption. To succeed, companies must focus on research and development to offer innovative and affordable UDCA drugs, collaborate with hepatologists to optimize treatment approaches, and address the challenges to meet the increasing demand for effective and well-tolerated therapeutic options for liver and gallbladder disorders.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Ursodeoxycholic Acid market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Dr. Falk Pharma
Daewoong Pharmaceutical
Teva
Epic Pharma
Mitsubishi Tanabe Pharma
Lannett
Mylan
Bruschettini
Impax
Shanghai Pharma
Grindeks
Segment by Type
Tablet
Capsule
Segment by Application
Gallstones
Liver Disease
Stomach Trouble
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Ursodeoxycholic Acid report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Ursodeoxycholic acid, whose chemical name is 3a,7β-dihydroxy-5β-cholestane-24-acid, is an organic compound with an odorless, bitter taste. It is used in medicine to increase the secretion of bile acid, change the composition of bile, reduce cholesterol and cholesterol lipid in bile, and help the cholesterol in gallstones to gradually dissolve.
Global Oral Ursodeoxycholic Acid market is projected to reach US$ 3436.9 million in 2029, increasing from US$ 1628 million in 2022, with the CAGR of 11.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Ursodeoxycholic Acid market research.
The Ursodeoxycholic Acid (UDCA) drug market is driven by the increasing prevalence of liver and gallbladder disorders and the growing adoption of UDCA as an effective treatment option. UDCA is a naturally occurring bile acid that helps dissolve cholesterol-rich gallstones and aids in the treatment of certain liver diseases, such as primary biliary cholangitis (PBC) and nonalcoholic fatty liver disease (NAFLD). The rise in liver-related conditions and the need for improved therapeutic options contribute to market growth as UDCA offers a well-tolerated and disease-modifying treatment for these disorders. Moreover, advancements in drug formulations and the development of combination therapies have enhanced the efficacy of UDCA treatment. However, the market also faces challenges, including the cost of UDCA drugs and the need for further research to optimize dosing and treatment protocols. Additionally, addressing regulatory requirements and ensuring accessibility to patients can pose obstacles for broader adoption. To succeed, companies must focus on research and development to offer innovative and affordable UDCA drugs, collaborate with hepatologists to optimize treatment approaches, and address the challenges to meet the increasing demand for effective and well-tolerated therapeutic options for liver and gallbladder disorders.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Ursodeoxycholic Acid market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Dr. Falk Pharma
Daewoong Pharmaceutical
Teva
Epic Pharma
Mitsubishi Tanabe Pharma
Lannett
Mylan
Bruschettini
Impax
Shanghai Pharma
Grindeks
Segment by Type
Tablet
Capsule
Segment by Application
Gallstones
Liver Disease
Stomach Trouble
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Ursodeoxycholic Acid report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Oral Ursodeoxycholic Acid Market Overview
1.1 Product Overview and Scope of Oral Ursodeoxycholic Acid
1.2 Oral Ursodeoxycholic Acid Segment by Type
1.2.1 Global Oral Ursodeoxycholic Acid Market Value Comparison by Type (2023-2029)
1.2.2 Tablet
1.2.3 Capsule
1.3 Oral Ursodeoxycholic Acid Segment by Application
1.3.1 Global Oral Ursodeoxycholic Acid Market Value by Application: (2023-2029)
1.3.2 Gallstones
1.3.3 Liver Disease
1.3.4 Stomach Trouble
1.3.5 Other
1.4 Global Oral Ursodeoxycholic Acid Market Size Estimates and Forecasts
1.4.1 Global Oral Ursodeoxycholic Acid Revenue 2018-2029
1.4.2 Global Oral Ursodeoxycholic Acid Sales 2018-2029
1.4.3 Global Oral Ursodeoxycholic Acid Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oral Ursodeoxycholic Acid Market Competition by Manufacturers
2.1 Global Oral Ursodeoxycholic Acid Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oral Ursodeoxycholic Acid Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oral Ursodeoxycholic Acid Average Price by Manufacturers (2018-2023)
2.4 Global Oral Ursodeoxycholic Acid Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oral Ursodeoxycholic Acid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Ursodeoxycholic Acid, Product Type & Application
2.7 Oral Ursodeoxycholic Acid Market Competitive Situation and Trends
2.7.1 Oral Ursodeoxycholic Acid Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Ursodeoxycholic Acid Players Market Share by Revenue
2.7.3 Global Oral Ursodeoxycholic Acid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Ursodeoxycholic Acid Retrospective Market Scenario by Region
3.1 Global Oral Ursodeoxycholic Acid Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oral Ursodeoxycholic Acid Global Oral Ursodeoxycholic Acid Sales by Region: 2018-2029
3.2.1 Global Oral Ursodeoxycholic Acid Sales by Region: 2018-2023
3.2.2 Global Oral Ursodeoxycholic Acid Sales by Region: 2024-2029
3.3 Global Oral Ursodeoxycholic Acid Global Oral Ursodeoxycholic Acid Revenue by Region: 2018-2029
3.3.1 Global Oral Ursodeoxycholic Acid Revenue by Region: 2018-2023
3.3.2 Global Oral Ursodeoxycholic Acid Revenue by Region: 2024-2029
3.4 North America Oral Ursodeoxycholic Acid Market Facts & Figures by Country
3.4.1 North America Oral Ursodeoxycholic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oral Ursodeoxycholic Acid Sales by Country (2018-2029)
3.4.3 North America Oral Ursodeoxycholic Acid Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Ursodeoxycholic Acid Market Facts & Figures by Country
3.5.1 Europe Oral Ursodeoxycholic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oral Ursodeoxycholic Acid Sales by Country (2018-2029)
3.5.3 Europe Oral Ursodeoxycholic Acid Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Ursodeoxycholic Acid Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Ursodeoxycholic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oral Ursodeoxycholic Acid Sales by Country (2018-2029)
3.6.3 Asia Pacific Oral Ursodeoxycholic Acid Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Ursodeoxycholic Acid Market Facts & Figures by Country
3.7.1 Latin America Oral Ursodeoxycholic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oral Ursodeoxycholic Acid Sales by Country (2018-2029)
3.7.3 Latin America Oral Ursodeoxycholic Acid Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Ursodeoxycholic Acid Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Ursodeoxycholic Acid Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oral Ursodeoxycholic Acid Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oral Ursodeoxycholic Acid Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Ursodeoxycholic Acid Sales by Type (2018-2029)
4.1.1 Global Oral Ursodeoxycholic Acid Sales by Type (2018-2023)
4.1.2 Global Oral Ursodeoxycholic Acid Sales by Type (2024-2029)
4.1.3 Global Oral Ursodeoxycholic Acid Sales Market Share by Type (2018-2029)
4.2 Global Oral Ursodeoxycholic Acid Revenue by Type (2018-2029)
4.2.1 Global Oral Ursodeoxycholic Acid Revenue by Type (2018-2023)
4.2.2 Global Oral Ursodeoxycholic Acid Revenue by Type (2024-2029)
4.2.3 Global Oral Ursodeoxycholic Acid Revenue Market Share by Type (2018-2029)
4.3 Global Oral Ursodeoxycholic Acid Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oral Ursodeoxycholic Acid Sales by Application (2018-2029)
5.1.1 Global Oral Ursodeoxycholic Acid Sales by Application (2018-2023)
5.1.2 Global Oral Ursodeoxycholic Acid Sales by Application (2024-2029)
5.1.3 Global Oral Ursodeoxycholic Acid Sales Market Share by Application (2018-2029)
5.2 Global Oral Ursodeoxycholic Acid Revenue by Application (2018-2029)
5.2.1 Global Oral Ursodeoxycholic Acid Revenue by Application (2018-2023)
5.2.2 Global Oral Ursodeoxycholic Acid Revenue by Application (2024-2029)
5.2.3 Global Oral Ursodeoxycholic Acid Revenue Market Share by Application (2018-2029)
5.3 Global Oral Ursodeoxycholic Acid Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Dr. Falk Pharma
6.1.1 Dr. Falk Pharma Corporation Information
6.1.2 Dr. Falk Pharma Description and Business Overview
6.1.3 Dr. Falk Pharma Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Dr. Falk Pharma Oral Ursodeoxycholic Acid Product Portfolio
6.1.5 Dr. Falk Pharma Recent Developments/Updates
6.2 Daewoong Pharmaceutical
6.2.1 Daewoong Pharmaceutical Corporation Information
6.2.2 Daewoong Pharmaceutical Description and Business Overview
6.2.3 Daewoong Pharmaceutical Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Daewoong Pharmaceutical Oral Ursodeoxycholic Acid Product Portfolio
6.2.5 Daewoong Pharmaceutical Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Teva Oral Ursodeoxycholic Acid Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Epic Pharma
6.4.1 Epic Pharma Corporation Information
6.4.2 Epic Pharma Description and Business Overview
6.4.3 Epic Pharma Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Epic Pharma Oral Ursodeoxycholic Acid Product Portfolio
6.4.5 Epic Pharma Recent Developments/Updates
6.5 Mitsubishi Tanabe Pharma
6.5.1 Mitsubishi Tanabe Pharma Corporation Information
6.5.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.5.3 Mitsubishi Tanabe Pharma Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mitsubishi Tanabe Pharma Oral Ursodeoxycholic Acid Product Portfolio
6.5.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.6 Lannett
6.6.1 Lannett Corporation Information
6.6.2 Lannett Description and Business Overview
6.6.3 Lannett Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Lannett Oral Ursodeoxycholic Acid Product Portfolio
6.6.5 Lannett Recent Developments/Updates
6.7 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mylan Oral Ursodeoxycholic Acid Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Bruschettini
6.8.1 Bruschettini Corporation Information
6.8.2 Bruschettini Description and Business Overview
6.8.3 Bruschettini Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bruschettini Oral Ursodeoxycholic Acid Product Portfolio
6.8.5 Bruschettini Recent Developments/Updates
6.9 Impax
6.9.1 Impax Corporation Information
6.9.2 Impax Description and Business Overview
6.9.3 Impax Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Impax Oral Ursodeoxycholic Acid Product Portfolio
6.9.5 Impax Recent Developments/Updates
6.10 Shanghai Pharma
6.10.1 Shanghai Pharma Corporation Information
6.10.2 Shanghai Pharma Description and Business Overview
6.10.3 Shanghai Pharma Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Shanghai Pharma Oral Ursodeoxycholic Acid Product Portfolio
6.10.5 Shanghai Pharma Recent Developments/Updates
6.11 Grindeks
6.11.1 Grindeks Corporation Information
6.11.2 Grindeks Oral Ursodeoxycholic Acid Description and Business Overview
6.11.3 Grindeks Oral Ursodeoxycholic Acid Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Grindeks Oral Ursodeoxycholic Acid Product Portfolio
6.11.5 Grindeks Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Ursodeoxycholic Acid Industry Chain Analysis
7.2 Oral Ursodeoxycholic Acid Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Ursodeoxycholic Acid Production Mode & Process
7.4 Oral Ursodeoxycholic Acid Sales and Marketing
7.4.1 Oral Ursodeoxycholic Acid Sales Channels
7.4.2 Oral Ursodeoxycholic Acid Distributors
7.5 Oral Ursodeoxycholic Acid Customers
8 Oral Ursodeoxycholic Acid Market Dynamics
8.1 Oral Ursodeoxycholic Acid Industry Trends
8.2 Oral Ursodeoxycholic Acid Market Drivers
8.3 Oral Ursodeoxycholic Acid Market Challenges
8.4 Oral Ursodeoxycholic Acid Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
